SEARCH

SEARCH BY CITATION

References

  • 1
    Alvar J, Canavate C, Gutierrez-Solar B et al. (1997) Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clinical Microbiology Reviews 10 , 298319.
  • 2
    Ben Salah AB, Ben Ismail R, Amri F et al. (2000) Investigation of the spread of human visceral leishmaniasis in central Tunisia. Transactions of the Royal Society of Tropical Medicine and Hygiene 94 , 382386.
  • 3
    Berman JD (1988) Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies. Reviews in Infectious Diseases 10 , 560586.
  • 4
    Berman JD, Chulay JD, Hendricks LD, Oster CN (1982) Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. American Journal of Tropical Medicine and Hygiene 31 , 459465.
  • 5
    Bryceson A (1987) Therapy in man. In: Leishmaniasis in Biology and Medicine (eds W Peters & R Killick-Kendrick) Academic Press, London, pp. 847–907.
  • 6
    Bryceson AD, Chulay JD, Ho M et al. (1985a) Visceral leishmaniasis unresponsive to antimonial drugs. I. Clinical and immunological studies. Transactions of the Royal Society of Tropical Medicine and Hygiene 79 , 700704.
  • 7
    Bryceson AD, Chulay JD, Mugambi M et al. (1985b) Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine. Transactions of the Royal Society of Tropical Medicine and Hygiene 79 , 705714.
  • 8
    Chulay JD, Bhatt SM, Muigai R et al. (1983) A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Journal of Infectious Diseases 148 , 148155.
  • 9
    Chulay JD, Fleckenstein L, Smith DH (1988) Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Transactions of the Royal Society of Tropical Medicine and Hygiene 82 , 6972.
  • 10
    Chunge CN, Gachihi G, Muigai R et al. (1985) Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Transactions of the Royal Society of Tropical Medicine and Hygiene 79 , 715718.
  • 11
    Chunge CN, Owate J, Pamba HO, Donno L (1990) Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Transactions of the Royal Society of Tropical Medicine and Hygiene 84 , 221225.
  • 12
    Costa CH, Pereira HF, Araujo MV (1990) Epidemia de leishmaniose visceral no estado do Piaui, Brasil, 1980–1986. Revista de Saude Publica 24 , 361372.
  • 13
    Davidson RN & Russo R (1994) Relapse of visceral leishmaniasis in patients who were co-infected with human immunodeficiency virus and who received treatment with liposomal amphotericin B. Clinical Infectious Diseases 19 , 560560 (letter).
  • 14
    Di Giorgio C, Faraut-Gambarelli F, Imbert A et al. (1999) Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantum isolates from patients with visceral leishmaniasis. Journal of Antimicrobial Agents Chemotherapy 44 , 7176.
  • 15
    Dogra J (1991) A double-blind study on the efficacy of oral dapsone in cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 85 , 212213.
  • 16
    Ellard GA (1984) Rationale of the multi drug regimens recommended by a WHO study group on chemotherapy of leprosy for control programmes. International Journal of Leprosy 52 , 394401.
  • 17
    Gramiccia M, Gradoni L, Orsini S (1992) Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Annals of Tropical Medicine and Parasitology 86 , 613620.
  • 18
    Halim MA, Alfurayh O, Kalin ME et al. (1993) Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate. Clinical Infectious Diseases 16 , 397399.
  • 19
    Jha TK, Olliaro P, Thakur CP et al. (1998) Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. British Medical Journal 316 , 12001205.
  • 20
    Jha TK, Sundar S, Thakur CP et al. (1999) Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. New England Journal of Medicine 341 , 17951800.
  • 21
    Lal SK, Lal R, Lal S, Lal BN (1996) Experience with roxithromycin in visceral leishmaniasis in north Bihar. Journal of the Association of Physicians of India 44 , 615617.
  • 22
    Lira R, Sundar S, Makharia A et al. (1999) Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. Journal of Infectious Diseases 180 , 564567.
  • 23
    Lopez Velez R, Perez Molina JA, Guerrero A et al. (1998) Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients co-infected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain. American Journal of Tropical Medicine and Hygiene 58 , 436443.
  • 24
    Mishra M, Biswas UK, Jha AM, Khan AB (1994) Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar. Lancet 344 , 15991600.
  • 25
    Murray HW & Hariprashad J (1996) Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis. Antimicrobial Agents Chemotherapy 40 , 586587.
  • 26
    Raffi F, Merrien D, Le Pape P, Reliquet V (1995) Use of an itraconazole/allopurinol combination for the treatment of visceral leishmaniasis in a patient with AIDS. Clinical Infectious Diseases 21 , 13381339.
  • 27
    Rosenthal E, Marty P, Poizot Martin I et al. (1995) Visceral leishmaniasis and HIV-1 co-infection in southern France. Transactions of the Royal Society of Tropical Medicine and Hygiene 89 , 159162.
  • 28
    Saxena NB, Aggarwal V, Dhillon GP, Sharma RS &, Rao JS (1996) Visceral leishmaniasis control in India through primary health care system – a successful experiment of district level planning. Journal of Communicable Diseases 28 , 122128.
  • 29
    Seaman J, Pryce D, Sondorp HE et al. (1993) Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. Journal of Infectious Diseases 168 , 715720.
  • 30
    Seaman J, Mercer AJ, Sondorp E (1996) The epidemic of visceral leishmaniasis in western upper Nile, southern Sudan: course and impact from 1984 to 1994. International Journal of Epidemiology 25 , 862871.
  • 31
    Simpson JA, Watkins ER, Price RN et al. (2000) Mefloquine pharmacokinetic–pharmacodynamic models: implications for dosing and resistance. Antimicrobial Agents Chemotherapy 44 , 34143424.
  • 32
    Sundar S, Singh VP, Agrawal NK, Gibbs DL, Murray HW (1996) Treatment of kala-azar with oral fluconazole. Lancet 348 , 614614 (letter).
  • 33
    Sundar S, Makharia A, More DK et al. (2000a) Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clinical Infectious Diseases 31 , 11101113.DOI: 10.1086/318122
  • 34
    Sundar S, More DK, Singh MK et al. (2000b) Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clinical Infectious Diseases 31 , 11041107.DOI: 10.1086/318121
  • 35
    Thakur CP, Bhowmick S, Dolfi L, Olliaro P (1995) Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial. Transactions of the Royal Society of Tropical Medicine and Hygiene 89 , 219223.
  • 36
    Thakur CP, Sinha GP, Pandey AK (1996) Comparison of regimens of amphotericin B deoxycholate in kala-azar. Indian Journal of Medical Research 103 , 259263.
  • 37
    Torrus D, Boix V, Massa B, Portilla J, Perez Mateo M (1996) Fluconazole plus allopurinol in treatment of visceral leishmaniasis. Journal of Antimicrobial Chemotherapy 37 , 10421043.
  • 38
    Wali JP, Aggarwal P, Gupta U, Saluja S, Singh S (1992) Ketoconazole in the treatment of antimony- and pentamidine-resistant kala-azar. Journal of Infectious Diseases 166 , 215216.
  • 39
    White NJ (1999) Delaying antimalarial drug resistance with combination chemotherapy. Parasitologia 41 , 301308.
  • 40
    White NJ, Van Vugt M, Ezzet F (1999) Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clinical Pharmacokinetics 37 , 105125.